- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on ALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLC in China
Total 1745 results
-
PfizerCompletedALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLCUnited States, Canada, Australia, Taiwan, Singapore, Japan, Korea, Republic of, Spain, Belgium, Switzerland, France, Germany, Hong Kong, Italy
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownROS1-positive Non-Small Cell Lung Cancer (NSCLC)China
-
Peking University Cancer Hospital & InstituteBetta Pharmaceuticals Co., Ltd.RecruitingNSCLC Stage IV | NSCLC Stage IIIB | ALK PositiveChina
-
PfizerTerminatedALK or ROS1-positive NSCLCChina
-
Bristol-Myers SquibbCompletedLung Cancer | Non-small Cell Lung Cancer NSCLC | Small Cell Lung Cancer SCLCChina
-
Tongji UniversityRecruitingNSCLC | EGF-R Positive Non-Small Cell Lung CancerChina
-
AstraZenecaCompletedT790M Positive NSCLC PatientsChina
-
The First Affiliated Hospital with Nanjing Medical...RecruitingMetastatic NSCLC | Recurrent NSCLC | Advanced Non-Small Cell Squamous Lung CancerChina
-
Guangzhou Institute of Respiratory DiseaseShanghai Junshi Bioscience Co., Ltd.UnknownIIIb/IV NSCLC With T790M Positive Mutations Failed to Osimertinib TherapyChina
-
Tongji UniversityRecruitingA Phase III Trial of Neoadjuvant Sintilimab and Chemotherapy for NSCLC Harboring No Driver MutationsNSCLC, Stage IIIA | EGF-R Negative Non-Small Cell Lung Cancer | ALK Negative NSCLCChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingUntreated Advanced NSCLC Patients | FISH Identified ALK Fusion Positive or NegativeChina
-
CStone PharmaceuticalsPfizerActive, not recruitingAdvanced or Metastatic ROS1-Positive Non-Small Cell Lung CancerChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Unknown
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Unknown
-
Liaoning Tumor Hospital & InstituteNot yet recruitingNSCLC | EGF-R Positive Non-Small Cell Lung CancerChina
-
Shanghai Chest HospitalRecruitingNon-Small Cell Lung Cancer (NSCLC)China
-
Jiangsu HengRui Medicine Co., Ltd.Shanghai Pulmonary Hospital, Shanghai, ChinaCompletedNon-Small Cell Lung Cancer (NSCLC)China
-
Beijing Haidian Hospital307 Hospital of PLA; Peking University People's Hospital; 309th Hospital of Chinese...RecruitingThe Role of Icotinib in the Perioperative Treatment of IIIA - IIIB NSCLC Patients With EGFR MutationNon-small Cell Lung Cancer(NSCLC)China
-
Sun Yat-sen UniversityNot yet recruitingNSCLC | Non-small Cell Lung CancerChina
-
Second Affiliated Hospital, School of Medicine,...Tongji Hospital; Qilu Hospital of Shandong University; First Hospital of China... and other collaboratorsRecruitingPembrolizumab | Non-small-lung-cell Cancer, NSCLCChina
-
Daping Hospital and the Research Institute of Surgery...Xinqiao Hospital of Chongqing; First Affiliated Hospital of Chongqing Medical...Completed
-
Shanghai Miracogen Inc.Not yet recruitingNon-small- Cell Lung Cancer (NSCLC)China
-
Innovent Biologics (Suzhou) Co. Ltd.Terminated
-
The Affiliated Hospital of Qingdao UniversityRecruitingNon-small-cell Lung Cancer (NSCLC)China
-
Haining Health-Coming Biotech Co., Ltd.Alphacait, LLCUnknownNon-small Cell Lung Cancer (NSCLC)China
-
Simcere Pharmaceutical Co., LtdUnknownNon-small Cell Lung Cancer (NSCLC)China
-
Daping Hospital and the Research Institute of Surgery...CompletedNSCLC | Advanced Cancer | EGFR Gene Amplification | Stage IV NSCLC | Stage IIIB NSCLCChina
-
Jinming YuRecruitingNon-small Cell Lung Cancer (NSCLC)China
-
Pingping SongNot yet recruitingNon-Small Cell Lung Cancer(NSCLC)China
-
Jinming YuRecruitingNon-small Cell Lung Cancer (NSCLC)China
-
Xiaorong DongUnknownHealthy Subjects | NSCLC Stage IV | NSCLC, Stage III | NSCLC, Stage I | NSCLC, Stage IIChina
-
Jiangsu HengRui Medicine Co., Ltd.CompletedNon-small Cell Lung Cancer(NSCLC)China
-
Jiangsu HengRui Medicine Co., Ltd.Sun Yat-sen University; Shanghai Pulmonary Hospital, Shanghai, ChinaSuspendedNon-Small Cell Lung Cancer (NSCLC)China
-
Tang-Du HospitalActive, not recruitingNon-small-cell Lung Cancer (NSCLC)China
-
Xuanzhu Biopharmaceutical Co., Ltd.Not yet recruiting
-
Peking Union Medical CollegeRecruitingNSCLC Stage IV | EGFR Activating Mutation | NSCLC Stage IIIB | NSCLC, RecurrentChina
-
Shandong New Time Pharmaceutical Co., LTDNot yet recruitingNSCLC | Non-small Cell Lung Cancer | PD-1China
-
Shanghai Gebaide Biotechnology Co., Ltd.UnknownNon-small-cell Lung Cancer (NSCLC) Stage IVChina
-
TakedaCompletedALK-positive Advanced NSCLCJapan
-
Qianfoshan HospitalRecruitingMetastatic NSCLC | Locally Advanced Non-Small Cell Lung CancerChina
-
Shanghai Yizhong Biotechnology Co., Ltd.UnknownNon-Small Cell Lung Cancer(NSCLC)China
-
Simcere Pharmaceutical Co., LtdUnknownAdvanced NSCLC | Recurrent NSCLCChina
-
Shanghai Chest HospitalThe Affiliated Hospital of Qingdao University; Zhejiang University; Anhui Provincial...Active, not recruitingNSCLC Stage IV | NSCLC Stage IIIB | NSCLC Stage IIICChina
-
Yantai LNC Biotechnology Singapore PTE. LTD.Not yet recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedNSCLC (Non-small-cell Lung Cancer)China
-
Shanghai Pharmaceuticals Holding Co., LtdWithdrawn
-
Ariad PharmaceuticalsTakedaActive, not recruitingALK-positive Advanced NSCLCKorea, Republic of, United States, Spain, Taiwan, Canada, Hong Kong, China, Sweden, Australia, Italy, Japan, Germany, Netherlands, France, Austria
-
Shanghai Henlius BiotechRecruiting
-
Yongchang ZhangRecruitingHER2 Insertion Mutation Positive Advanced NSCLCChina
-
Shanghai Chest HospitalRecruitingNSCLC | NSCLC Stage IV | NSCLC, RecurrentChina